Literature DB >> 25592121

Unintentional secondary exogenous corticosteroid exposure and central serous chorioretinopathy.

S Thinda1, K Lam1, S S Park1.   

Abstract

PURPOSE: The purpose of this study is to describe a possible association between unintentional secondary exogenous corticosteroid exposure and central serous chorioretinpathy (CSCR).
METHODS: A retrospective review of three patients diagnosed with CSCR in one or both eyes and a history of possible unintentional secondary corticosteroid exposure. Clinical history, exam findings, optical coherence tomography, fluorescein angiography, and clinical course were reviewed.
RESULTS: Three patients, who did not use corticosteroids, reported suspected unintentional secondary corticosteroid exposure from living with family members or partners using dermatologic corticosteroid cream and/or inhalers frequently. Two of the three patients had a history of recurrent CSCR, one patient involving both eyes. After taking precautions to avoid secondary corticosteroid exposure, all three patients had complete resolution of CSCR without further recurrence during follow-up ranging from 2 to 4 years.
CONCLUSIONS: Patients with CSCR should be queried for both primary and possible unintentional secondary routes of corticosteroid exposure, which may contribute to this condition.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25592121      PMCID: PMC4816351          DOI: 10.1038/eye.2014.328

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  9 in total

1.  Electrophysiological effects of corticosteroids on the retinal pigment epithelium.

Authors:  C Arndt; A Sari; M Ferre; E Parrat; D Courtas; J De Seze ; J Hache; R Matran
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

Review 2.  Central serous chorioretinopathy and glucocorticoids.

Authors:  Evrydiki A Bouzas; Panagiotis Karadimas; Constantin J Pournaras
Journal:  Surv Ophthalmol       Date:  2002 Sep-Oct       Impact factor: 6.048

Review 3.  Glucocorticoids and vascular reactivity.

Authors:  Shumei Yang; Lubo Zhang
Journal:  Curr Vasc Pharmacol       Date:  2004-01       Impact factor: 2.719

Review 4.  Central serous chorioretinopathy: an update on pathogenesis and treatment.

Authors:  M Gemenetzi; G De Salvo; A J Lotery
Journal:  Eye (Lond)       Date:  2010-10-08       Impact factor: 3.775

5.  Central serous chorioretinopathy: a personal perspective.

Authors:  Lawrence A Yannuzzi
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

Review 6.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

7.  'Blow-outs' in the retinal pigment epithelium.

Authors:  B G Goldstein; P R Pavan
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

Review 8.  Glucocorticoid action on connective tissue: from molecular mechanisms to clinical practice.

Authors:  A I Oikarinen; J Uitto; J Oikarinen
Journal:  Med Biol       Date:  1986

9.  Risk factors for central serous chorioretinopathy: a case-control study.

Authors:  Robert Haimovici; Sean Koh; David R Gagnon; Todd Lehrfeld; Sarah Wellik
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.